ACM
BSX icon

Advent Capital Management’s Boston Scientific BSX Stock Holding History

Advent Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,000
Closed -$2.86M – 220
2025
Q4 		$2.86M Buy
+30,000
New +$2.94M 0.06% 170
2017
Q3 		– Sell
-23,000
Closed -$638K – 300
2017
Q2 		$638K Buy
+23,000
New +$610K 0.01% 198

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Advent Capital Management's BSX Position: Q1 2026 in Review

Advent Capital Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 30,000 shares — an estimated $2.86M sold.

Advent Capital Management first reported a position in BSX in Q2 2017 and held it in 2 quarters. The position peaked at $2.86M in Q4 2025. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Advent Capital Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Advent Capital Management sold 30,000 Boston Scientific shares in Q1 2026, an estimated $2.86M.
  • Advent Capital Management first reported a position in Boston Scientific in Q2 2017 and held it in 2 quarters.
  • Advent Capital Management's Boston Scientific position peaked at $2.86M in Q4 2025.
  • 1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Advent Capital Management's 13F filing for Q1 2026, filed 7 May 2026.